SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CBD Life Sciences Inc. – ‘1-K’ for 12/31/19

On:  Wednesday, 4/29/20, at 11:24am ET   ·   For:  12/31/19   ·   Accession #:  1683168-20-1307

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/20  CBD Life Sciences Inc.            1-K        12/31/19    2:200K                                   GlobalOne Filings Inc/FA

Annual Report — Reg. A   —   Form 1-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-K         Annual Report -- Reg. A -- primary_doc.xml          HTML      4K 
 2: PART II     Annual Report - Part II -- Reg. A - Form 1-K        HTML    118K 


‘1-K’   —   Annual Report — Reg. A — primary_doc.xml




        

This ‘1-K’ Document is an XML Data File that may be rendered in various formats:

  Form 1-K    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Annual Report or Special Financial Report
 
schemaVersion:

1-K: Filer Information

Issuer CIK
0001776073 
Issuer CCC
XXXXXXXX 
Is filer a shell company? Radio button not checked Yes Radio button checked No
Is the electronic copy of an official filing submitted in paper format? Checkbox not checked
File Number
 
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? Radio button not checked Yes Radio button checked No
Successor File Number
 
Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST
Would you like a Return Copy? Checkbox not checked
Period
12/31/19 

Submission Contact Information

Name
 
Phone
 
E-Mail Address
 
Notify via Filing Website only? Checkbox not checked

1-K: Tab 1 Notification

This Form 1-K is to provide an Radio button checked Annual Report Radio button not checked Special Financial Report for the fiscal year
Fiscal Year End

12/31/19 

Exact name of issuer as specified in the issuer's charter

CBD Life Sciences, Inc. 

CIK

0001776073 

Jurisdiction of Incorporation / Organization

NEVADA  

I.R.S. Employer Identification Number

20-5118532 

Address of Principal Executive Offices

Address 1

10855 N. 116th Street Suite 115 

Address 2

 

City

Scottsdale 

State/Country

ARIZONA  

Mailing Zip/ Postal Code

85259 

Phone

480-410-6780 

Title of each class of securities issued pursuant to Regulation A

Common Stock 


Top
Filing Submission 0001683168-20-001307   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 6:22:14.1am ET